Evidence map›Paper›PMID 26440606›Full record

ArticleBrain topography2016

The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects.

Farshad Falahati, Daniel Ferreira, Hilkka Soininen, Patrizia Mecocci, Bruno Vellas, Magda Tsolaki, Iwona Kłoszewska, Simon Lovestone, Maria Eriksdotter, Lars-Olof Wahlund and 3 more

Abstract readMulticenter Study
In one paragraph

Article in Brain topography, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Farshad FalahatiDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Plan 5, 141 57, Stockholm, Sweden. farshad.falahati@ki.se.ORCID http://orcid.org/0000-0003-0851-4615
Daniel FerreiraDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Plan 5, 141 57, Stockholm, Sweden.
Hilkka SoininenDepartment of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
Patrizia MecocciInstitute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy.
Bruno VellasINSERM U 558, University of Toulouse, Toulouse, France.
Magda Tsolaki3rd Department of Neurology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Iwona KłoszewskaMedical University of Lodz, Lodz, Poland.
Simon LovestoneInstitute of Psychiatry, King's College London, London, UK.
Maria EriksdotterDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Plan 5, 141 57, Stockholm, Sweden.
Lars-Olof WahlundDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Plan 5, 141 57, Stockholm, Sweden.
Andrew SimmonsInstitute of Psychiatry, King's College London, London, UK.
Eric WestmanDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Plan 5, 141 57, Stockholm, Sweden.
AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

The similarity of atrophy patterns in Alzheimer's disease (AD) and in normal aging suggests age as a confounding factor in multivariate models that use structural magnetic resonance imaging (MRI) data. To study the effect and compare different age correction approaches on AD diagnosis and prediction of mild cognitive impairment (MCI) progression as well as investigate the characteristics of correctly and incorrectly classified subjects. Data from two multi-center cohorts were included in the study [AD = 297, MCI = 445, controls (CTL) = 340]. 34 cortical thickness and 21 subcortical volumetric measures were extracted from MRI. The age correction approaches involved: using age as a covariate to MRI-derived measures and linear detrending of age-related changes based on CTL measures. Orthogonal projections to latent structures was used to discriminate between AD and CTL subjects, and to predict MCI progression to AD, up to 36-months follow-up. Both age correction approaches improved models' quality in terms of goodness of fit and goodness of prediction, as well as classification and prediction accuracies. The observed age associations in classification and prediction results were effectively eliminated after age correction. A detailed analysis of correctly and incorrectly classified subjects highlighted age associations in other factors: ApoE genotype, global cognitive impairment and gender. The two methods for age correction gave similar results and show that age can partially masks the influence of other aspects such as cognitive impairment, ApoE-e4 genotype and gender. Age-related brain atrophy may have a more important association with these factors than previously believed.

Indexed as

AgedAged, 80 and overAge FactorsAgingAlzheimer DiseaseAnalysis of VarianceAtrophyBrainCognitive DysfunctionCohort StudiesDiagnostic ErrorsDisease ProgressionEarly DiagnosisFemaleHumansImage Processing, Computer-AssistedAge correctionAlzheimer’s diseaseDiagnostic misclassificationEarly diagnosisMild cognitive impairmentMRIOPLS

Identifiers

PMID26440606
PMCPMC4754326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.